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Myoepithelial cells are ectodermal origin cells found in secre-
tary organs like salivary glands, breast, skin, and kidney
[1,2]. Sheldon was the ﬁrst to identify Myoepithelial tumours
as a distinct salivary gland tumour entity [3].
Myoepitheliomas are unusual and uncommon tumours and
constitute only 1–1.5% of all salivary gland tumours [4]. In
the literature till now only one case of Myoepithelial carci-
noma of the base of the tongue has been described.
Rationale in reporting this 22 year old patient is to illustrate
the diagnostic and therapeutic dilemma encountered.Case report
A 22 year old male patient presented to our multidisciplinary
head and neck cancer clinic with complaints of non healing
ulcer over the posterior part of left side of the tongue for
6 months, difﬁculty in swallowing for 4 months, dull aching
pain, non radiating for 4 months. The patient did not give
any history of smoking, alcoholism, sharp teeth or oral sexual
habits. He had no history of malignancy in the family. He had
a performance status of ECOG-One [European cooperative
oncology group]. Oral examination and laryngoscopy revealed
a 4 * 3 cm sized ulcer-proliferative growth on the posterior
1/3rd of the tongue on the left side and extending to the base
of the tongue. Neck node examination was found normal. A
biopsy from the edge of the ulcer with normal tissue was taken
and was reported as poorly differentiated carcinoma and pos-
itive for cytokeratin. Hence, a ﬁnal diagnosis was achieved as
carcinoma tongue, CT2 N0 M0. The patient was planned for
46 B. Venkatesulu et al.wide local excision and ipsilateral selective neck dissection fol-
lowed by adjuvant radiotherapy. The patient underwent trans-
oral laser excision of the left posterior 1/3rd and base of tongue
tumour with supra-omohyoid neck dissection and tra-
cheostomy under general anaesthesia. Post operative recovery
was uneventful.
The histopathology revealed a mass size of 4 * 3 cm.
Microscopic examination revealed a poorly differentiated
malignant tumour. Tumour cells were arranged in diffuse
sheets. There was evidence of perineural invasion. Tumour
cells were focally immune positive for cytokeratin (CK),
epithelial membrane antigen (EMA), smooth muscle actin
(SMA) and vimentin and negative for synaptophysin, Neu-
IV chromogranin leucocyte common antigen (LCA), desmin,
Myogenin, and MIC-2, HMB-45, CD54, GFAP and S-100
protein (Fig. 1). Features were in favour of Myoepithelial car-
cinoma. None of the nine dissected lymph nodes revealed evi-
dence of metastasis. Subsequently, the patient received
postoperative radiotherapy 50 Gray in 25 fractions over
5 weeks with 5 fractions per week by the 3DCRT technique.
The radiotherapy was planned in Eclipse treatment planning
system with a 6 MV photon beam. The patient tolerated the
treatment well with no treatment interruptions and no major
toxicity reported. The patient was kept on regular follow up
with clinical examination every 3 months and CECT face
and neck repeated every 6 months.
After three and half years of symptom free interval he pre-
sented with chest pain and breathlessness for 1 month. Chest
X-ray was ordered and opacity in left upper and middle zone
was found. Contract enhanced computed tomography
(CECT chest and face and neck) was done which revealed
postoperative changes with surgical drops at the base of the
tongue and moderate pleural effusion on the left side with a
partial collapse of the underlying lung showing patchy consol-
idation ﬁbrosis without any evidence of mediastinal
lymphadenopathy.
Patient was evaluated in an pulmonary medicine clinic and
advised CT guided biopsy of the lung mass. Microscopy
revealed small cell carcinoma of the lung with areas of necro-
sis. Tumour cells were immune-positive for synaptophysin,
chromogranin and focally for cytokeratin, MIB1 labelling
index is approximately 90%.
Subsequently he was started on chemotherapy with cis-
platin 30 mg/m2 and etoposide 100 mg/m2 intravenous (IV)Figure 1 (A) Photomicrograph showing tumour arranged in diffuse
cells show scant rim of cytoplasm, vesicular nucleus, prominent eosino
H&E stain).day one through day three repeated every 3 weekly for six
cycles. At the time of writing this case report the patient was
being planned for thoracic radiation and prophylactic cranial
irradiation.Discussion
Squamous cell carcinomas are the most common histology of
the base of the tongue with >90% of patients diagnosed with
SCC. Human papilloma virus has been found to be an aetio-
logical factor for tumours of the oropharynx. Myoepithelial
carcinoma may arise from minor salivary glands of the base
of the tongue. According to World Health Organization histo-
logical classiﬁcation of salivary gland tumours Myoepithelial
carcinoma has been recognized as a distinct entity from 1991
and accorded a morphology code of 8982/3 of the
International classiﬁcation of disease for oncology (ICO-O)
[5]. The very low historic incidence is probably due to their
recent recognition as a separate tumour entity. Myoepithelial
carcinoma is known to occur in partial, submandibular, sub-
lingual, minor salivary gland, hard palate, breast, lung, soft tis-
sue, kidney, paranasal sinus, trachea, nasal cavity and lacrimal
gland [6–8].
Myoepithelial cells exhibit 4 main cell morphologies: spin-
dle (most common), epithelioid, plasmacytoid and clear cells
(least common). Myoepithelial cells are found usually to be
positive for cytokeratin (AEI/AE3, CK 5/6, Cam 52, CK-7
and CK-14) and vimentin (positive in neoplastic
Myoepithelial cell and negative in normal Myoepithelial cells.
Neoplastic transformation of Myoepithelial cells results in loss
or modiﬁcation of their smooth muscle phenotype resulting in
positivity of S100 calponin, smooth muscle actin (SMA), mus-
cle speciﬁc actin (MSA), smooth muscle myosin, p53 protein
and glial ﬁbrillary acidic protein (GFAP). Myoepithelial cells
are typically negative for carcino-embryonic antigen (CEA),
signifying no tubular differentiation and E-cadherin expression
also detected in myoepithelioma [9–11]. Our patient was
focally immune positive for cytokeratin, epithelial membrane
antigen, smooth muscle actin and vimentin. Malignant myoep-
ithelioma are a distinct entity from epithelial Myoepithelial
neoplasms and should not be confused to entertain a diagnosis
of malignant myoepithelioma. Cytokeratin and other
Myoepithelial markers including smooth muscle actin,sheets and inﬁltrating into the skeletal muscle (10·). (B) Tumour
philic nucleus and moderate degree of anisonucleosis (40·) (both
Table 1 Pathological and immunochemistry details of reported cases.
S.
No.
Author Histopathology Immunohistochemistry Diagnostic imaging used
1 Casas et al. (2001)
[12]
Myoepithelioma S-100+, GFAP+Muscle speciﬁc actin+ No imaging stage NA
2 Puri et al. (2004)
[13]
Epithelial Myoepithelial
tumour
Cytokeratin (AE1/3) negative smooth muscle
actin+, CK+
Stage CT3 N0M0 (only clinical
examination)
3 Kei Woo et al.
(2005) [14]
Myoepithelioma S-100+, vimentin + Leu7, p63+ Imaging used stage NA
4 Kumai et al. (2006)
[15]
Epithelial Myoepithelial
tumour
Cytokeratin+, Smooth muscle actin+, S-
100+
Stage* CT2 N0M0 (MRI** used)
5 DeMatos et al.
(2009) [16]
Epithelial Myoepithelial
tumour
Cytokeratin + Smooth muscle actin+ CT1 N0M0 (MRI used)
6 Peters et al. (2010)
[17]
Epithelial Myoepithelial
carcinoma
P53 + CK 5/6 + CK34 + SMA+AEI/
AE3+
CT2 N0M0 (MRI used)
7 Present case (2014) Malignant
myoepithelioma
Cytokeratin + EMA+ SMA+ Vimentin+ CT2 N0M0 no imaging
* Staging done according to the American Joint Committee on Cancer Research, AJCC 2008 (TNM staging).
** MRI – magnetic resonance imaging.
Table 2 Clinical features, treatment details and end status details of reported cases.
S.No. Author Site of lesion Age/sex Treatment modality Follow up Recurrence
1 Casas et al.
(2001) [12]
Midline cystic
tongue lesion
65/M Complete resection 10 months No recurrence at last follow up
2 Puri et al.
(2004) [13]
Base of
tongue
48/M Neo-adjuvant Chemotherapy cisplatin,
5 ﬂuorouracil · 2 cyclesﬁ 66 Gy RT
14 months No recurrence at last follow up
3 Kei Woo
et al. (2005)
[14]
Midline
dorsal lesion
19/F EL excision 14 months No recurrence at last follow up
4 Kumai et al.
(2006) [15]
Base of
tongue
76/M Surgery (subtotal glossectomy, b/l
neck dissection, and reconstruction)
19 months No recurrence at last follow up
5 de Matos
et al. (2009)
[16]
Ventral
surface of
tongue
48/F 1st surgery Excision biopsy 7 years Recurrence at 4 years, No further
recurrence at 7 years
6 Peters et al.
(2010) [17]
Base of
tongue
60/F End surgery WLE RT 60 Gy/30#/
6 weeks
NR No recurrence at last follow up
7 Present case
(2014)
Base of
tongue
22/M Transoral laser
surgery + supraondyoid neck
dissectionﬁ RT 50 GY/25#
42 months No recurrence but second new
primary in the lung (small cell
carcinoma)
Small cell carcinoma of lung in a treated 47GFAP, CD10 calponin and smooth muscle myosin hearing
heavy chain are required for diagnosis.
We found only 6 cases of myoepithelioma of the tongue
reported till date. Two cases had a benign myoepithelioma;
four had epithelial-Myoepithelial carcinoma. The present case
had malignant myoepithelioma, a distinct entity from other
histology. The pathological and immuno-histochemistry
details of the reported cases have been summarized in
Table 1 [12–17]. Table 2 summarizes the clinical, treatment
details and end results of the reported cases [12–17].
In the management of tumour due to its enigmatic presen-
tation and rarity different modalities of surgery and radio-
chemotherapy have been applied. There was a concurrence
for surgery in the form of wide local excision for 4 patients
and radiotherapy was used in 3 patients. Since the present
patient had the largest follow up of 42 months and in head
and neck cancer maximum recurrence occured within
6 months of treatment completion, we may claim that initialsurgery followed by a radiation dose of 50 Gy could be sufﬁ-
cient for adequate local control.
Another unusual aspect of our case was after 3 and ½ years
of symptom free interval, patients developed a second new pri-
mary of small cell carcinoma of the lung [18,19]. There have
been case reports of myoepithelioma of the lung. But in the
present case immunohistochemistry was positive for synapto-
physin, chromogranin and cytokeratin, and does not favour
myoepithelioma. Whether Myoepithelial malignancy of the
tongue and small cell carcinoma of the lung have really any
cytogenetic or molecular association or was it just a coinci-
dence is not known.Conclusion
What is the rationale in reporting those rare cases? In a high
volume tertiary referral hospital like ours, unknown cases
48 B. Venkatesulu et al.are seen more frequently with a catalogue of individual experi-
ences and a database could be built in respect to behaviour and
treatment options, so a standard surgical approach and radia-
tion dose could be devised for this uncommon and rarely diag-
nosed neoplasm.
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